Clinical Trial Update: Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluated a triple-drug regimen of gemcitabine, oxaliplatin, and capecitabine in locally advanced or metastatic pancreatic cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED